Literature DB >> 11177116

Progressive brain volume changes and the clinical course of schizophrenia in men: a longitudinal magnetic resonance imaging study.

D H Mathalon1, E V Sullivan, K O Lim, A Pfefferbaum.   

Abstract

BACKGROUND: We sought to determine whether the brain dysmorphology previously observed cross-sectionally in people with schizophrenia progresses over time and whether such progression is related to the severity of the illness course. SUBJECTS AND METHODS: Men with chronic schizophrenia (n = 24) and control men (n = 25) received 2 brain magnetic resonance imaging scans, on average 4 years apart. Changes in brain volume were adjusted for head-repositioning error and expressed as slopes (cubic centimeters per year). Clinical course severity for the schizophrenic patients was assessed using the mean of time 1 and time 2 Brief Psychiatric Rating Scale (BPRS) scores and the percentage of time the patient was hospitalized during the interscan interval.
RESULTS: Schizophrenic patients exhibited faster volume decline than control subjects in right frontal gray matter and bilateral posterior superior temporal gray matter, as well as faster cerebrospinal fluid volume expansion in right frontal sulci, left lateral ventricle, and bilateral prefrontal and posterior superior temporal sulci. Faster rates of frontal sulcal expansion were related to greater BPRS total and positive symptom scores and longer time hospitalized. Prefrontal gray matter decline and sulcal expansion were associated with greater BPRS negative symptom scores and longer time hospitalized. Temporal lobe gray matter decline was associated with greater BPRS total and negative symptom scores.
CONCLUSIONS: This controlled study revealed that patients with chronic schizophrenia exhibited accelerated frontotemporal cortical gray matter decline and cortical sulcal and lateral ventricular expansion. Further, greater clinical severity was associated with faster rates of frontotemporal brain volume changes. These observations are consistent with a progressive pathophysiological process but need to be replicated in a larger sample.

Entities:  

Mesh:

Year:  2001        PMID: 11177116     DOI: 10.1001/archpsyc.58.2.148

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  111 in total

1.  Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia.

Authors:  P M Thompson; C Vidal; J N Giedd; P Gochman; J Blumenthal; R Nicolson; A W Toga; J L Rapoport
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

Review 2.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

3.  Could stress cause psychosis in individuals vulnerable to schizophrenia?

Authors:  Cheryl Corcoran; Lilianne Mujica-Parodi; Scott Yale; David Leitman; Dolores Malaspina
Journal:  CNS Spectr       Date:  2002-01       Impact factor: 3.790

Review 4.  [Changes in brain structure caused by neuroleptic medication].

Authors:  H Scherk; P Falkai
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

5.  Automated classification of fMRI during cognitive control identifies more severely disorganized subjects with schizophrenia.

Authors:  Jong H Yoon; Danh V Nguyen; Lindsey M McVay; Paul Deramo; Michael J Minzenberg; J Daniel Ragland; Tara Niendham; Marjorie Solomon; Cameron S Carter
Journal:  Schizophr Res       Date:  2012-01-25       Impact factor: 4.939

6.  The neurodevelopmental model of schizophrenia: what can very early onset cases tell us?

Authors:  Judith L Rapoport; Anjene Addington; Sofia Frangou
Journal:  Curr Psychiatry Rep       Date:  2005-04       Impact factor: 5.285

7.  MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms.

Authors:  Beng-Choon Ho
Journal:  Schizophr Res       Date:  2007-08-29       Impact factor: 4.939

Review 8.  Prevention of schizophrenia: can it be achieved?

Authors:  Cheng Lee; Thomas H McGlashan; Scott W Woods
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

Review 9.  Review of pathological hallmarks of schizophrenia: comparison of genetic models with patients and nongenetic models.

Authors:  Hanna Jaaro-Peled; Yavuz Ayhan; Mikhail V Pletnikov; Akira Sawa
Journal:  Schizophr Bull       Date:  2009-11-10       Impact factor: 9.306

10.  Right-hemisphere encephalopathy in elderly subjects with schizophrenia: evidence from neuropsychological and brain imaging studies.

Authors:  V S Gabrovska-Johnson; M Scott; S Jeffries; N Thacker; R C Baldwin; A Burns; S W Lewis; J F W Deakin
Journal:  Psychopharmacology (Berl)       Date:  2003-07-04       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.